Acumen Pharmaceuticals Inc

Market Cap

$188M

Healthcare·Biotechnology·🇺🇸 United States·NASDAQ

Healthcare·Biotechnology·🇺🇸·NASDAQ

Stock Price

$2.15+$0.13 (+6.44%)

Jun 5, 2026

52W High $3.3752W Low $1.07

Company Details

Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops targeted therapies for the treatment of Alzheimer's disease. It focuses on advancing a targeted immunotherapy drug candidate, sabirnetug (ACU193), which is i...

CEO

—

IPO Date

Jul 1, 2021

Website

acumenpharm.com

Key Metrics TTM

Revenue

-100.0% YoY

Net Income

-$113M

EPS (Diluted)

Free Cash Flow

-$106M

Revenue / Share

$0.00

Gross Margin

Operating Margin

Net Margin

FCF Margin

P/S

P/E

Earnings Reports

Q1 2026

May 12, 2026

FY 2025

Mar 26, 2026

Q4 2025

Mar 26, 2026

$0-100.0%

Q3 2025

Nov 12, 2025

Q2 2025

Aug 12, 2025

Revenue & Profitability

Valuation

Operating Cash Flow

CapEx Spend

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

War Chest

Shares Outstanding

Revenue Per Employee

Revenue / Employee